Cleave-stage Transfer on Day 3 Versus Day 5 Transfer When Only One Embryo Available
NCT ID: NCT04210414
Last Updated: 2022-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
83 participants
INTERVENTIONAL
2020-01-10
2021-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing the Ongoing Pregnancy Rate for Vitrification of Day-4 Morula With Day-5 Blast
NCT03787901
Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Protocols
NCT05014867
Day 3 Fresh Transfer Followed by Day 3 or Day 5 Vitrification of Supernumerary Embryos
NCT04196036
Optimal Timing For Embryo Transfer For Low Responder Patients
NCT01040247
Effectiveness of PGT-A: IVF Versus ICSI
NCT03708991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Day 3 transfer
Transfer on day 3 when only one embryo is available
Embryo transfer
Transfer of only one embryo
Day 5 transfer
Transfer on day 5 when only one embryo is available
Embryo transfer
Transfer of only one embryo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Embryo transfer
Transfer of only one embryo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ibn Sina Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Fawzy
IVF Lab Director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qena Fertility Center
Qina, Qena Governorate, Egypt
Banon Assiut
Asyut, , Egypt
IbnSina IVF Center, IbnSina Hospital
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IbnSina-ET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.